BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Business

  Furiex Pharmaceuticals, Inc. Says Johnson & Johnson Returns Sexual Dysfunction Drug Rights

  May 15, 2012

   · 

  1 min read
• BioCapital

  How Payers View Pfizer Inc.'s Rheumatoid Arthritis Pill

  May 15, 2012

   · 

  1 min read
• Business

  Bristol-Myers Squibb Company and Tsinghua University Enter Strategic Partnership

  May 15, 2012

   · 

  2 min read
• Deals

  Cancer Genetics, Inc. Plans $48.6 Million IPO

  May 15, 2012

   · 

  1 min read
• Biotech Bay

  Sonitus Medical Closes on $25 Million

  May 15, 2012

   · 

  4 min read
• FDA

  St. Jude Medical Announces European Approval, Launch of EnligHTN System for Treatment of Hypertension

  May 15, 2012

   · 

  5 min read
• FDA

  Abbott Vascular XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

  May 15, 2012

   · 

  3 min read
• Deals

  CryoLife, Inc. to Acquire Hemosphere for Up to $21.4 Million

  May 15, 2012

   · 

  14 min read
• Career Advice

  New Survey Reveals How Biopharma Professionals Are Using Social Media

  May 15, 2012

   · 

  2 min read
• Drug Development

  Lundbeck Inc. Soars on Phase 3 Study Results for Experimental Antidepressant

  May 15, 2012

   · 

  1 min read